Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis
Open Access
- 25 April 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (17)
Abstract
Significance: High-grade serous ovarian carcinoma (HGSOC) is an immunotherapy-resistant lethal cancer. An HGSOC hallmark is elevated checkpoint pathway ligand expression that limits antitumor immune responses. Computational, preclinical, and patient tumor multiplexed analyses revealed that tumor-associated focal adhesion kinase (FAK) activation regulates CD155 expression, a checkpoint ligand for TIGIT (T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains). Using an aggressive mouse ovarian tumor model, we find that combined oral FAK inhibitor plus function-blocking TIGIT antibody immunotherapy reduced tumor burden, prolonged mouse survival, and led to immune cell activation and tertiary lymphoid structure formation, hallmarks of an antitumor immune response. As FAK is commonly overexpressed in HGSOC tumors, targeting FAK and TIGIT may limit tumor immune evasion.Keywords
Funding Information
- DOD | United States Army | MEDCOM | Congressionally Directed Medical Research Programs (W81XWH19101)
- HHS | NIH | National Cancer Institute (R01CA24756)
- HHS | NIH | National Cancer Institute (R01CA254342)
- Ovarian Cancer Research Fund (OCRA 650255)
- HHS | NIH | National Cancer Institute (T32-CA121938)
This publication has 50 references indexed in Scilit:
- Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian CancerClinical Cancer Research, 2016
- nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)Journal for ImmunoTherapy of Cancer, 2015
- TIGIT predominantly regulates the immune response via regulatory T cellsJournal of Clinical Investigation, 2015
- Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor ImmunityCell, 2015
- Molecular and cellular insights into T cell exhaustionNature Reviews Immunology, 2015
- Tumor infiltrating lymphocytes in ovarian cancerCancer Biology & Therapy, 2015
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector FunctionCancer Cell, 2014
- FAK in cancer: mechanistic findings and clinical applicationsNature Reviews Cancer, 2014
- Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier functionJournal of Cell Biology, 2014
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013